Analyst Ratings for Amneal Pharmaceuticals (AMRX)
AMRX Rating Summary
AMRX Price Target Summary
- Highest: $18.00 (JPMorgan)
- Lowest: $13.00 (Piper Sandler)
- Average: $15.75
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$15.75 (+19%)
* Over Last 12-Mos
Rating Score: 5 / 10
Percentile Rank: 52%
Avg. $ Target:
$15.75 (+19%)
* Over Last 12-Mos
Rating Score: 5 / 10
Percentile Rank: 52%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 12/9/2025 | Barclays | Glen Santangelo | New Coverage | Overweight (N/A) |
15.00 (N/A) |
12.18 (13.24) |
8.7% | Details |
| 6/6/2025 | Goldman Sachs | Matt Dellatorre | New Coverage | Neutral (N/A) |
12.00 (N/A) |
7.21 (13.24) |
83.63% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
